The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kociková, A.
Right arrow Articles by Elbe-Bürger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kociková, A.
Right arrow Articles by Elbe-Bürger, A.
The Journal of Immunology, 1998, 161: 4033-4041.
Copyright © 1998 by The American Association of Immunologists

Murine Langerhans Cells Cultured Under Serum-Free Conditions Mature into Potent Stimulators of Primary Immune Responses In Vitro and In Vivo1

Alena Kociková*, Andrea Kolesaric*, Frieder Koszik{dagger}, Georg Stingl* and Adelheid Elbe-Bürger2,*

* Department of Dermatology, Division of Immunology, Allergy and Infectious Diseases, University of Vienna Medical School, Vienna International Research Cooperation Center, Vienna, Austria; and {dagger} Department of Cellular and Molecular Biology, Novartis Research Institute, Vienna, Austria

The ability of Ag-pulsed dendritic cells (DC) to induce primary immune responses has led them to be used for vaccination purposes. However, irrelevant Ags (e.g., FCS) can also be taken up by DC during their isolation and culture and then presented in vivo. To circumvent this, we have established a serum-free (SF) culture system. Murine epidermal cell (EC) suspensions were prepared with and without FCS and cultured for 3 days either in SF or FCS-containing medium. In spite of the lower Langerhans cell (LC) yields under SF conditions, both SF- and FCS-cultured LC (SF-cLC, FCS-cLC) underwent a similar maturation process, as evidenced by a similar increase in the cell surface expression of MHC class II and of costimulatory molecules. The further observation that SF-EC cultures elaborated comparable amounts of granulocyte-macrophage (GM)-CSF as FCS-cultured EC, but were relatively impaired in their IL-1{alpha} and TNF-{alpha} production, supports the role of GM-CSF in LC maturation and, less so, in LC survival. Functionally, freshly isolated SF-LC compared with FCS-LC in their Ag-processing capacity. Three-day-cultured SF-LC were as potent stimulators of polyclonal T cell responses and of the primary allogeneic MLR as FCS-cLC, but were relatively poor activators of naive, syngeneic CD4+ T cells. In vivo, hapten-modified SF-cLC induced a contact hypersensitivity response similar in magnitude and kinetics to that evoked by FCS-cLC. Our data show that, in the absence of serum and exogenous cytokines, LC mature into potent activators of T cell responses and could thus be a valuable cellular source for DC-based immunotherapy.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
K. Kabashima, N. Shiraishi, K. Sugita, T. Mori, A. Onoue, M. Kobayashi, J.-i. Sakabe, R. Yoshiki, H. Tamamura, N. Fujii, et al.
CXCL12-CXCR4 Engagement Is Required for Migration of Cutaneous Dendritic Cells
Am. J. Pathol., October 1, 2007; 171(4): 1249 - 1257.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Luhrs, W. Schmidt, R. Kutil, M. Buschle, S. N. Wagner, G. Stingl, and A. Schneeberger
Induction of Specific Immune Responses by Polycation-Based Vaccines
J. Immunol., November 1, 2002; 169(9): 5217 - 5226.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Riedl, J. Stockl, O. Majdic, C. Scheinecker, W. Knapp, and H. Strobl
Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation
Blood, December 15, 2000; 96(13): 4276 - 4284.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.